Eccogene

Pharmaceutical Manufacturing • Cambridge, Massachusetts, United States • 21-50 Employees

Company overview

Headquarters	255 Main St, Cambridge, Massachusetts 02142, US
Website	eccogene.com
NAICS	3254
Keywords	Metabolism, Small Molecule, Immune
Founded	2018
Employees	21-50
Socials

Key Contacts at Eccogene

Jingye Zhou

Co-Founder And Ceo

Jianfeng Jeff Hang

Senior Director, Quality

Linda Kong

Human Resources Director

Sun Xuefeng

Director Of Medicinal Chemistry

Laurie Butcher

Director Clinical Operations

Binbin Kou

Director Of Peptide Science

Zhanling Cheng

Senior Director

Jia Zou

Director Of Immunology

Claire Wang

Associate Legal Director

Eccogene Email Formats

Eccogene uses 5 email formats. The most common is {first initial}.{last name} (e.g., j.doe@eccogene.com), used 40% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@eccogene.com	55%
{first name}.{last name}	john.doe@eccogene.com	25%
{first initial}{last name}	jdoe@eccogene.com	10%
{first initial}	j@eccogene.com	5%

About Eccogene

Eccogene is focused on building a pipeline of best-in-class small molecule therapeutics for chronic cardiometabolic and inflammatory conditions with the goal of improving care and expanding access to cost effective medicines for millions of patients worldwide. Since our inception, our team has been dedicated to discovering safer and more effective oral therapies that may be used alone or synergistically with a GLP-1 receptor agonist to treat conditions beyond obesity. Among our core strengths is our team -- comprised of individuals with world-class expertise in translational research and small molecule discovery -- as well as our deep understanding of diabetes, weight loss and cardiometabolic disease pathways. Our oral small molecule GLP-1 receptor agonist, ECC5004, is a potentially best-in-class asset, which we licensed to AstraZeneca. To expand on the opportunity in cardiometabolic disease, we are also advancing clinical programs targeting THR-β and SSAO, as well as preclinical programs targeting proven pathways, such as GIP. We invite you to read more about our company on our website at www.eccogene.com

Eccogene revenue & valuation

Annual revenue	$6,000,000
Revenue per employee	$231,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$19,200,000
Total funding	$25,200,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

Entry

C-Suite

Employees by Department

Eccogene has 12 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Eccogene's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-12	5	$25,200,000

Funding Insights

$25,200,000

Total funding amount

$25,200,000

Most recent funding amount

Number of funding rounds

Eccogene Tech Stack

Discover the technologies and tools that power Eccogene's digital infrastructure, from frameworks to analytics platforms.

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

GoDaddy

Hosting

MonsterInsights

Analytics

PHP

Programming languages

Open Graph

Miscellaneous

HSTS

Security

Tengine

Web servers

WordPress

Blogs

jQuery Migrate

JavaScript libraries

WordPress Super Cache

Caching

Google Analytics

Analytics

Frequently asked questions

Eccogene is located in Cambridge, Massachusetts, US.

Eccogene was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Eccogene has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Eccogene has raised a total of $25,200,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.